000 02796cam a2200349 a 4500
003 EG-GiCUC
005 20250223031826.0
008 171015s2017 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.28.Ph.D.2017.Ma.L
100 0 _aMariam Saad Soliman Nassim
245 1 0 _aLiver iron concentration and serum hepcidin levels in patients with beta thalassemia /
_cMariam Saad Soliman Nassim ; Supervised Ilham Youssry Ibrahim , Hadeel Mohammed Seif Eldein Aly , Rania Mohamed Samy Mohamed
246 1 5 _aمستوى الحديد بالكبد و مستوى الهبسيدين بالدم لدى مرضى انيميا البحر الابيض المتوسط
260 _aCairo :
_bMariam Saad Soliman Nassim ,
_c2017
300 _a179 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Pediatrics
520 _aThe aim of this study was to assess serum hepcidin levels among transfusion and non transfusion dependent thalassemia patients, to radiologically evaluate iron level in different tissues, to find a correlation between serum hepcidin and the studied iron overload indices and to identify the risk factors of iron overload. Methods: Eighty six thalassemia patients (56 TDT and 30 NTDT) were all subjected to history taking, clinical examination, and laboratory testing including full blood picture, serum ferritin detected by enzyme linked fluorescent assay, serum hepcidin: detected by enzyme linked immunosorbent assay . HAMP gene polymorphisms were detected using PCR-RFLP technique. Thirty six patients had a liver MRI (15 NTDT and 22 TDT) in which the pancreas and adrenal glands were visualized in eighteen patients (12 TDT and 6 NTDT) and twenty one had a heart MRI (14 TDT and 7 NTDT). Results: In this study, mean serum hepcidin was higher among TDT patients than NTDT patients. Among our patients,16.6% did not have liver iron overload (LIC<2mg/kg dw), 38.8% had mild iron overload (LIC 2-6 mg/kg dw), and 44.4% had moderate to severe iron overload (LIC >6mg/kg dw). Out of 21 evaluated patients: 4.5% had severe cardiac siderosis (T2*<10ms), 4.5% had moderate cardiac siderosis (T2* 10-20ms) and 91% had no cardiac iron overload (T2*>21ms). 61% of the studied patients demonstrated pancreatic T2*<21ms
530 _aIssued also as CD
653 4 _aHepcidin
653 4 _aNTDT
653 4 _aTDT
700 0 _aHadeel Mohammed Seif Eldein Aly ,
_eSupervisor
700 0 _aIlham Youssry Ibrahim ,
_eSupervisor
700 0 _aRania Mohamed Samy Mohamed ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c62960
_d62960